Garrick Talmage, MD
Otolaryngology · Parker, CONPI 1124481668
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,860 of the $3,430 with a category attached, or 83.4%. 8 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 57.9% of the total. Reporting peaked in 2021 at $1,501 and has fallen 60.6% since, to $592 in 2025.
Across 40 payments — averaging $85.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$2K
- Stryker$684
- Sanofi$484
- Genentech USA, Inc.$121
- Medtronic$79
- Cochlear Americas$31
- plus $45 from 2 others
What the payments were for
- Travel & lodging$57017%
- Food & beverage$2,86083%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 18 | $1,985 |
| Stryker | 6 | $684 |
| Sanofi | 10 | $484 |
| Genentech USA, Inc. | 1 | $121 |
| Medtronic | 1 | $79 |
| Cochlear Americas | 2 | $31 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Optinose US, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire Upper Airway Stimulation System$1,128
- Inspire$508
- DUPIXENT$362
- NA$342
- SMARTLOCK$342
- MINIFESS TURBINATE FORCEPS$168
- XPRESS ENT DILATION SYSTEM$155
- SCOPIS ENT$155
- CLARIFIX CRYOTHERAPY DEVICE$155
- LATERA$155
- XEROGEL NASAL/EPISTAXIS 2 PACK$131
- Erivedge$121
How this compares
$3,430 in reported general payments places this provider in the 80th percentile of 174 otolaryngology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 67 | $1,648 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 20 | $221 |
| Omeprazole | 12 | $60 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Parker
- Suzanne BertramFort Collins$475K
- Barton KnoxColorado Springs$164K
- Nicholas BeckmannColorado Springs$151K
- Vijay RamakrishnanAurora$128K
- Michael WilhelmColorado Springs$76K
- Andrew WinklerAurora$68K
- David OppermanDenver$67K
- Robert KellerColorado Springs$45K
- Peter SchmidLongmont$45K
- Ashoke KhanwalkarAurora$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.